Novavax’s COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request more data beyond the April 1 deadline.
FDA Delays Full Approval Decision On Novavax’s COVID-19 Vaccine (UPDATED)
Where Today's News Shapes Tomorrow
